Vice President, U.S. Sarcoma Marketing

SpringWorks Therapeutics

1 month ago

4.2 on Glassdoor

Boston, MA

Hybrid

Full Time

Executive

5 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Vice President, U.S. Sarcoma Marketing is a senior commercial leader at SpringWorks Therapeutics responsible for the commercial vision and execution for the company’s sarcoma portfolio, including treatments for Desmoid Tumors and TGCT. This role sits within the U.S. Rare Tumors Marketing leadership team and partners across commercial, medical, access, and external stakeholders to advance rare sarcoma therapies and drive sustainable growth.

Skills

Qualifications

BS/BA in Business or Related DisciplineMBA (Preferred)

About SpringWorks Therapeutics

springworkstx.com

SpringWorks Therapeutics is a commercial-stage biopharmaceutical company that applies a precision‑medicine approach to discover, develop, and deliver targeted therapies for severe rare diseases and cancer. Focused on targeted oncology, the company pursues potential breakthrough medicines with scientific rigor, urgency, and a patient‑centric mindset. SpringWorks combines research and development expertise with commercial capabilities to advance and bring life‑changing treatments to patients.

Recent company news

Merck Group

Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

Jul 1, 2025

Fierce Biotech

Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal

1 week ago

World Pharmaceutical Frontiers

Merck completes $3.4bn acquisition of SpringWorks Therapeutics

Jul 2, 2025

Law360

Biopharma Co. Can't Beat Former Exec's Age, Race Bias Suit

3 days ago

Yahoo Finance

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

Oct 20, 2025